1: \begin{abstract}

2:   We consider estimation of an optimal individualized treatment rule

3:   from observational and randomized studies when a high-dimensional

4:   vector of baseline variables is available. Our optimality criterion

5:   is with respect to delaying expected time to occurrence of an event

6:   of interest (e.g., death or relapse of cancer). We leverage

7:   semiparametric efficiency theory to construct estimators with

8:   desirable properties such as double robustness. We propose two

9:   estimators of the optimal rule, which arise from considering two

10:   loss functions aimed at (i) directly estimating the conditional

11:   treatment effect (also know as the blip function), and (ii)

12:   recasting the problem as a weighted classification problem that uses

13:   the 0-1 loss function. Our estimated rules are \textit{super

14:     learning} ensembles that minimize the cross-validated risk of a

15:   linear combination in a user-supplied library of candidate

16:   estimators. We prove oracle inequalities bounding the finite sample

17:   excess risk of the estimator. The bounds depend on the excess risk

18:   of the oracle selector and a doubly robust term related to

19:   estimation of the nuisance parameters. We discuss some important

20:   implications of these oracle inequalities such as the convergence

21:   rates of the value of our estimator to that of the oracle

22:   selector. We illustrate our methods in the analysis of a phase III

23:   randomized study testing the efficacy of a new therapy for the

24:   treatment of breast cancer.

25: \end{abstract}

26: